{"id":29141,"date":"2023-01-17T13:42:19","date_gmt":"2023-01-17T08:12:19","guid":{"rendered":"http:\/\/finservwealth.com\/budget-2023-foreign-pharma-firms-push-for-fast-tracking-of-new-drug-approvals-ease-of-doing-business\/"},"modified":"2023-01-17T13:42:19","modified_gmt":"2023-01-17T08:12:19","slug":"budget-2023-foreign-pharma-firms-push-for-fast-tracking-of-new-drug-approvals-ease-of-doing-business","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/budget-2023-foreign-pharma-firms-push-for-fast-tracking-of-new-drug-approvals-ease-of-doing-business\/","title":{"rendered":"Budget 2023: Foreign pharma firms push for fast-tracking of new drug approvals, ease of doing business"},"content":{"rendered":"<p> Multinational drugmakers are seeking relaxation of norms that govern the launch of new medicines and clinical trials of drugs\u00c2\u00a0in India.<\/p><div id=\"finse-2284259744\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/economy\/budget-2023-foreign-pharma-firms-push-for-fast-trackingnew-drug-approvals-easedoing-business_16809081.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Multinational drugmakers are seeking relaxation of norms that govern the launch of new medicines and clinical trials of drugs\u00c2\u00a0in India. Multinational drugmakers are seeking relaxation of norms that govern the launch of new medicines and clinical trials of drugs\u00c2\u00a0in India.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/economy\/budget-2023-foreign-pharma-firms-push-for-fast-trackingnew-drug-approvals-easedoing-business_16809081.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> Multinational drugmakers are seeking relaxation of norms that govern the launch of new medicines and clinical trials of drugs\u00c2\u00a0in India.<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/economy\/budget-2023-foreign-pharma-firms-push-for-fast-trackingnew-drug-approvals-easedoing-business_16809081.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Multinational drugmakers are seeking relaxation of norms that govern the launch of new medicines and clinical trials of drugs\u00c2\u00a0in India. Multinational drugmakers are seeking relaxation of norms that govern the launch of new medicines and clinical trials of drugs\u00c2\u00a0in India.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/economy\/budget-2023-foreign-pharma-firms-push-for-fast-trackingnew-drug-approvals-easedoing-business_16809081.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> Multinational drugmakers are seeking relaxation of norms that govern the launch of new medicines and clinical trials of drugs\u00c2\u00a0in India.<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-29141","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2021\/200x200\/p\/pharma1-1_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/29141","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=29141"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/29141\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=29141"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=29141"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=29141"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}